U.S., Oct. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07876479) titled 'The Effect of Ablation Duration of Renal Denervation on Antihypertensive Efficacy' on Oct. 09.
Brief Summary: This is a prospective, multicenter, randomized controlled study designed to evaluate the effect of renal denervation (RDN) ablation duration on blood pressure reduction in patients with hypertension.
A total of 220 eligible patients with hypertension will be randomly assigned in a 1:1 ratio to one of two treatment groups. All participants will undergo renal denervation using a radiofrequency ablation system and a single-use multielectrode renal denervation catheter. In Group 1, each ablation site in the main renal arteries ...